Research

Results of a Remote Hypertension and Lipid Program in 10,000+ Patients

Do fully remote programs for hypertension and high cholesterol across diverse health systems improve equitable access to care?

Continue Reading

What Insights Will You Gain?

Readers will learn how a large health network scaled a remote hypertension and cholesterol program to over 10,800 patients using nonlicensed navigators, pharmacists, and standardized algorithms with results showing meaningfully lower blood pressure and LDL cholesterol among patients on remote medication management compared to those receiving education alone. For clinicians, this offers evidence that a navigator-and-pharmacist-led model, supported by task automation and home device data, can extend guideline-directed care to far more patients without requiring additional in-person visits or added clinician time. It's also useful for showing that these outcomes held consistently across different racial, ethnic, and language groups, making the case that remote care models like this can scale equitably rather than only benefiting patients who are easiest to reach.